Mesothelioma: Presurgery Radiation Feasible, Boosts SurvivalMesothelioma: Presurgery Radiation Feasible, Boosts Survival
Early results with intensity-modulated radiation followed by extrapleural pneumonectomy in resectable malignant pleural mesothelioma are 'encouraging'. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 23, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Mesothelioma Classification Change Affected Documentation of Mortality Rates
Studies conducted by the Centers for Disease Control (CDC) estimate that in the United States, at least 43,073 people have been killed by asbestos since 1979. However, they also state that this figure could account for as little as 20 percent of asbestos-related deaths. The CDC's assessment of mesothelioma mortality rates suggests that the number of nationwide asbestos-related deaths between 1979 and 2001 could be as high as 230,000 people. The significant difference between this figure and their original estimation is primarily attributed to the way the government classifies malignant mesothelioma deaths. Prior to 1998, m...
Source: Asbestos and Mesothelioma News - January 23, 2014 Category: Environmental Health Authors: Michelle Whitmer Tags: Treatment & Doctors Source Type: news

Radiation Before Surgery May Improve Survival From Rare Lung Cancer
Small study of mesothelioma patients also found smoother recovery with this treatment method (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 23, 2014 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Oncology, Surgery, News, Source Type: news

Radiation Before Surgery May Improve Survival From Rare Lung Cancer
Small study of mesothelioma patients also found smoother recovery with this treatment method (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - January 23, 2014 Category: Cancer & Oncology Source Type: news

Asbestos.com Survey Shows Need for Increased Awareness, Treatment Options
A majority of people had heard of asbestos, but were unaware of the seriousness of exposure to the deadly substance until they or a loved were diagnosed with an asbestos-related disease like mesothelioma, a recent Asbestos.com survey shows. The Mesothelioma Center at Asbestos.com in December 2013 conducted a survey that asked our online newsletter readers a series of personal questions related to mesothelioma, including type of treatment they or their loved ones received, recommendations they offered to others dealing with the incurable cancer, effectiveness of their local VA hospital and primary location of asbe...
Source: Asbestos and Mesothelioma News - January 21, 2014 Category: Environmental Health Authors: Nadia Persaud Tags: Treatment & Doctors Source Type: news

Using Betadine Antiseptic to Kill Mesothelioma Tumor Cells
Researchers in Italy are exploring the possibility of using a popular and traditional antiseptic as an alternative to chemotherapy for pleural irrigation after surgery with the hope of better preventing mesothelioma cancer recurrence. Early laboratory work done at the Second University of Naples has shown that Betadine brand iodine-based antiseptic, which has been used by doctors as a presurgery hand cleaner for decades, can suppress and destroy mesothelioma tumor cells. A study with surgical patients will begin soon to further determine the clinical benefits for mesothelioma treatment. "It's my dream t...
Source: Asbestos and Mesothelioma News - January 20, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Radiation before surgery more than doubles mesothelioma survival: UHN study
(University Health Network) Results of clinical research that treated mesothelioma with radiation before surgery show the three-year survival rate more than doubled for study participants afflicted with this deadly disease, compared to treating with surgery first. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 20, 2014 Category: Cancer & Oncology Source Type: news

Mesothelioma
Title: MesotheliomaCategory: Diseases and ConditionsCreated: 1/12/2000 9:18:00 AMLast Editorial Review: 1/17/2014 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 17, 2014 Category: Cancer & Oncology Source Type: news

Mesothelioma Stem Cell Research at PMC Holds Great Potential
The Pacific Heart, Lung & Blood Institute in California is moving forward with potentially groundbreaking stem cell mesothelioma research that could dramatically change the treatment of this disease. While mesenchymal stem cells already are utilized in therapies for several autoimmune diseases, the novel research will explore using them for the first time as a vehicle to deliver molecular and gene therapies directly to mesothelioma sites. The goal is to develop a reliable therapy to provide consistent, long-term survival for pleural mesothelioma patients, which currently doesn't exist. The majority of meso...
Source: Asbestos and Mesothelioma News - January 16, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

Pineapple Extract Enhances Chemo Effectiveness on Mesothelioma Cells
A future cancer treatment may have emerged with the recent discovery that bromelain, a pineapple extract, can improve the effectiveness of cisplatin chemotherapy on peritoneal mesothelioma tumor cells. Bromelain is an enzyme found in the stem and the juice of a pineapple. It has been part of the natural, alternative medicine culture for many years, dating back centuries in Central and South America. The pineapple enzyme may be close to moving into the realm of more conventional medicine in a very significant way, thanks to recent, groundbreaking research at the University of New South Wales in Australia. &...
Source: Asbestos and Mesothelioma News - January 10, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Yale Refuses to Revoke Stephan Schmidheiny's Honorary Degree
Prestigious Yale University, a world leader in higher education, has come under fire after rejecting a call to support victims of asbestos exposure, and bypassing the opportunity to use its influence in raising awareness to the cause. Yale University has refused to revoke the honorary degree it presented to Switzerland billionaire Stephan Schmidheiny . He was convicted in 2012 of creating the asbestos environmental disaster that caused at least 2,000 deaths in Italy and countless more around the world. The Ivy League school in 1996 awarded Schmidheiny, who was sentenced to 16 years in prison, the hono...
Source: Asbestos and Mesothelioma News - January 8, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Legislation, Laws & Litigation Source Type: news

Novel Engineering of Immune Cells Holds Promise for Mesothelioma Patients
Patients with advanced malignant pleural mesothelioma and metastatic pancreatic cancer received surprisingly positive results during a small, recent Phase I clinical trial involving a novel engineering of immune cells. The trial was done at the Abramson Cancer Center in Philadelphia, and the results were published in Cancer Immunology Research. It accentuated the growing belief that the next big step in combating mesothelioma will come from immunotherapy, which uses a patient's own immune system to fight deadly diseases. "These results, albeit preliminary, are very promising," said Carl H. June, M....
Source: Asbestos and Mesothelioma News - January 3, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

Top 10 Mesothelioma News Stories of 2013
There was plenty of good news within the tight-knit mesothelioma community in 2013, but some of it was mixed with disappointment. While significant advancements were made that continued hope for the future, there were reminders the fight against mesothelioma cancer remains an uphill battle. There is much work still to be done. Surgical techniques improved. Therapies got better. Diagnostics moved forward. Yet the progress on all fronts has been too slow, requiring more diligence and more commitment to raising awareness about this rare, but aggressive cancer caused by exposure to toxic asbestos. 1. Robotics C...
Source: Asbestos and Mesothelioma News - December 30, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

New Drug Shows Promise in Killing Mesothelioma Tumor Cells
There may be help on the horizon for future pleural mesothelioma patients needing an effective, first-line systemic chemotherapy regimen that doesn't exist today. The latest laboratory breakthrough could give them a much better chance at survival. A recently completed study of panobinostat, a new experimental drug, in combination with the standard cisplatin, showed promising results in killing mesothelioma tumor cells without harming the healthy ones, along with eliminating the often troubling side effects. The study, published in Genetics and Molecular Research, was conducted in Ankara, Turkey, at Gazi Un...
Source: Asbestos and Mesothelioma News - December 19, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

Annabel Freyberg: 'I am lucky to be surrounded by kindness'
Shortly after her nine-year-old daughter died, Annabel Freyberg was herself diagnosed with terminal cancer. Here Annabel, a former interiors editor of the Telegraph Magazine, describes how her family, friends and a curious assortment of therapists kept her cheerful to the end     (Source: Telegraph Health)
Source: Telegraph Health - December 16, 2013 Category: Consumer Health News Tags: mesothelioma Blossom neuroblastoma cancer Annabel Freyberg Source Type: news

New partnership to prioritise mesothelioma treatment uncertainties
Today is the launch of an important ‘Priority Setting Partnership’ (PSP) set up by the James Lind Alliance (JLA) to identify and prioritise unanswered questions about mesothelioma treatments. Mesothelioma is a rare and often fatal form of cancer with very poor survival rates. It is most commonly caused by breathing in asbestos dust. Mesothelioma usually... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - December 16, 2013 Category: American Health Source Type: news

Chest wall resection effective for recurrent mesothelioma
Salvage chest wall resection could lengthen survival in patients with isolated chest wall recurrence of malignant pleural mesothelioma, research indicates. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 16, 2013 Category: Cancer & Oncology Source Type: news

Chest wall resection effective for recurrent mesothelioma
Salvage chest wall resection could lengthen survival in patients with isolated chest wall recurrence of malignant pleural mesothelioma, research indicates. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - December 16, 2013 Category: Cancer & Oncology Source Type: news

Petition Aims to Build First Federally Funded Mesothelioma Program
As the youngest person to become chief of Naval Operations, Admiral Elmo Zumwalt played a major role in U.S. military history -- a war hero whose service spanned World War II, Korea and Vietnam. It's only appropriate that the Mesothelioma Center for Excellence at the VA West Los Angeles Medical Center is adopting his name. Zumwalt died from pleural mesothelioma cancer almost 14 years ago, an ending that far too many veterans have suffered, stemming from the once-extensive use of asbestos in the armed forces. His life was dedicated to those who bravely served their country. Now his memory will be, too. If th...
Source: Asbestos and Mesothelioma News - December 12, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Veterans & Military Source Type: news

Detecting Mesothelioma Earlier with New Blood Test, Nanotechnology
One of the biggest hurdles in combating mesothelioma cancer has been an inability to accurately diagnose the disease early enough to treat it effectively. Far too often, mesothelioma is not identified until it has metastasized, leading to a typically poor prognosis. Help may be coming in the future. Researchers in Zurich, Switzerland recently published a study involving new technology that may help detect mesothelioma much earlier than before with a simple, noninvasive blood test. Bernd Wollscheid, Ph.D., of the Institute of Molecular Systems Biology and lead researcher of the study, says the findings could...
Source: Asbestos and Mesothelioma News - December 6, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

High Dose Radiation with Pleurectomy Shows Promise in Controlling Mesothelioma
High dose radiation therapy, as a follow-up to aggressive pleurectomy/decortication surgery for patients with pleural mesothelioma, has produced impressive results in a recent Italian study. Researchers in the Department of Radiation Oncology at the Centro di Riferimento Oncologico di Aviano, in northern Italy, reported a median survival rate of 33 months for the 20 consecutive patients enrolled at the cancer institute. "We think our approach is a concrete alternative option for the cure of MPM (malignant pleural mesothelioma)," lead researcher Emilio Minatel, M.D., told Asbestos.com. "We have very e...
Source: Asbestos and Mesothelioma News - December 3, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

Congresswoman Carolyn McCarthy's Lawsuit Shines Light on Asbestos Dangers
Past exposure to asbestos will dramatically increase the chances of a smoker developing lung cancer, a fact that may gain considerable attention in the coming months by the high-profile lawsuit filed by U.S. Congresswoman Carolyn McCarthy, of New York. The 17-year veteran of Congress announced in June that doctors were treating her for lung cancer. McCarthy, 69, recently filed a lawsuit against multiple asbestos manufacturers, claiming their products significantly increased her risk of getting the disease. Her case was not the typical occupational asbestos exposure that involves directly working with the dangerous mi...
Source: Asbestos and Mesothelioma News - November 25, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Legislation, Laws & Litigation Source Type: news

Mesothelioma Research Takes a Hit with Tissue Bank Defunding
The future of the National Mesothelioma Virtual Tissue Bank is in jeopardy after its federal funding was eliminated earlier this year, sending researchers scrambling to find other options. As part of a budget-cutting move, the National Institute of Occupational Safety and Health (NIOSH) and Centers for Disease Control (CDC) eliminated the annual grant of more than $1 million, delivering a serious blow to future mesothelioma research. Mesothelioma is the rare, but aggressive cancer caused by exposure to asbestos. There is no cure and there are few treatment options, but recent advancements have been made des...
Source: Asbestos and Mesothelioma News - November 20, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

Second Round of Cytoreductive Surgery/HIPEC Could Benefit Mesothelioma Patients
Mesothelioma patients could benefit significantly from a second round of cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC), providing a survival advantage over those who do not receive it, according to cancer researchers in Tampa. The study, published in the Annals of Surgical Oncology, shows that researchers at the Moffitt Cancer Center in Tampa discovered that patients with peritoneal mesothelioma, who returned for a second HIPEC procedure, survived for almost three times as long as those who underwent only one procedure. "I don't think you can definitively say it's the way to go for everyo...
Source: Asbestos and Mesothelioma News - November 14, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

Overlooked Lymph Nodes Could Improve Staging, Treatment of Mesothelioma
The future of cancer staging and treatment of pleural mesothelioma patients can be improved by looking closely at particular lymph nodes. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - November 7, 2013 Category: Environmental Health Authors: TimPovtak Tags: Research & Clinical Trials Source Type: news

Surgeon Rodney Landreneau Returns to Louisiana to Treat Mesothelioma Patients
Rodney Landreneau, M.D., formerly of UPMC, returns to home town of Louisiana to treat mesothelioma patients at the Ochsner Cancer Institute in New Orleans. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 31, 2013 Category: Environmental Health Authors: TimPovtak Tags: Treatment & Doctors Source Type: news

Innovative Therapy Approach Focuses on Cancer Stem Cells Innovative Therapy Approach Focuses on Cancer Stem Cells
Clinical trials in mesothelioma and ovarian cancer are exploring an investigational agent, defactinib, that homes in on cancer stem cells. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Study shows putting aggressive cancer on a starvation diet slows tumour growth
Scientists researching one of Britain's deadliest rare cancers, mesothelioma, at Queen Mary's Barts Cancer Institute studied how cancer cells are not able to survive and continue growing when starved of the amino acid 'arginine'. Cells are normally able to make arginine themselves, but research found around half of tumours lacked this ability and need to be fed arginine in order to survive, leaving it vulnerable to starvation... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 31, 2013 Category: Consumer Health News Tags: Asbestos / Mesothelioma Source Type: news

Prognostic potential of rib cage lymph nodes in mesothelioma
For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes--known as the posterior intercostal lymph nodes--that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma. The findings were presented at the 15th World Conference on Lung Cancer. Physicians look to lymph nodes to stage essentially all cancers, including mesothelioma... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 30, 2013 Category: Consumer Health News Tags: Asbestos / Mesothelioma Source Type: news

NCI Research Unlocks Potential of Immunotoxins for Mesothelioma
Researchers at the National Cancer Institute discover a way to reduce mesothelioma tumors using SS1P immunotoxin in conjunction with two immune suppressors. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 29, 2013 Category: Environmental Health Authors: TimPovtak Tags: Research & Clinical Trials Source Type: news

MesoVATS: Improved Symptoms, Not Survival, in MesotheliomaMesoVATS: Improved Symptoms, Not Survival, in Mesothelioma
Keyhole surgery to remove the tumor from the pleura improved symptoms and quality of life, but not survival, when compared with talc pleurodesis. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 29, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Overlooked lymph nodes in rib cage have prognostic power for mesothelioma patients
(University of Pennsylvania School of Medicine) For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 28, 2013 Category: Global & Universal Source Type: news

Firefighters Face Increased Risk of Developing Cancers, Including Mesothelioma
NIOSH discovered an increased risk of mesothelioma among U.S. firefighters, and believes spreading awareness and protection will minimize this danger. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 25, 2013 Category: Environmental Health Authors: TimPovtak Tags: Asbestos Exposure & Bans Source Type: news

New Clinical Trial Tests Drug to Control Mesothelioma Cancer Stem Cells
The international clinical trial, which is expected to involve 350-400 patients across 11 countries, will study the cancer stem cell inhibitor defactinib. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 23, 2013 Category: Environmental Health Authors: TimPovtak Tags: Research & Clinical Trials Source Type: news

Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials
(University of Pennsylvania School of Medicine) Clinical trials are key to finding new cancer treatments, but with patient participation hovering around 5 percent, new strategies are needed to boost enrollment, particularly to study the rare cancers that have so few cases. One such strategy comes from a new abstract being presented Oct. 28 at the 15th World Conference on Lung Cancer from researchers at Perelman School of Medicine at the University of Pennsylvania studying mesothelioma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 23, 2013 Category: Global & Universal Source Type: news

Weighing the Value, Benefits of Continued Drug Tests on Chimpanzees
Animal rights advocates question funding of primate-based mesothelioma research, especially when new ethical treatments are being implemented. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 18, 2013 Category: Environmental Health Authors: mwhitmer Tags: Research & Clinical Trials Source Type: news

Character Actor Ed Lauter, 74, Dies from Mesothelioma
Actor Ed Lauter, known for his gritty roles in 'The Longest Yard' and 'Death Wish 3,' dies of asbestos-related cancer at the age of 74. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 18, 2013 Category: Environmental Health Authors: TimPovtak Tags: Celebrities Source Type: news

Congressman Bruce Vento’s Widow Continues His Fight Against Asbestos, Mesothelioma
Susan Vento continues late husband's legacy, pushing for asbestos ban, raising awareness of mesothelioma, and easing burden on cancer victims. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 16, 2013 Category: Environmental Health Authors: TimPovtak Tags: Legislation, Laws & Litigation Source Type: news

Congressman Bruce Vento's Widow Continues His Fight Against Asbestos, Mesothelioma
Susan Vento lost her husband -- longtime U.S. Congressman Bruce Vento -- to mesothelioma 13 years ago, but she never lost his passion to fight for what was right. She continues his work today, honoring his legacy. Vento has reignited her battle against the asbestos companies and the big business establishments that continue to push legislation on state and federal levels that aims to erode the rights of individuals seeking justice through the legal system. She is back calling legislators, writing letters and sending e-mails. Vento is also giving speeches, raising awareness to the threat, and toiling like she has throughout...
Source: Asbestos and Mesothelioma News - October 16, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Legislation, Laws & Litigation Source Type: news

Mesothelioma Survivor Celebrates Obamacare’s Promise
Mesothelioma survivor, Alexis Kidd, is hoping the Affordable Care Act will provide her cancer treatments, and allow her to see an oncologist. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 11, 2013 Category: Environmental Health Authors: TimPovtak Tags: Legislation, Laws & Litigation Source Type: news

Mesothelioma Survivor Celebrates Obamacare's Promise
Mesothelioma survivor Alexis Kidd has friends on both sides of the often-contentious debate over the Affordable Care Act – otherwise known as Obamacare -- and she doesn't like talking politics. She is too nice, too kind, and too giving to say anything bad about anyone else's opinion. She just wants to live a little longer. Kidd, 43, was thrilled to learn she finally can get health insurance again, which will allow her to see an oncologist for the first time in almost four years. She can discover how much the peritoneal mesothelioma has progressed inside her. And possibly get treatment to save -- or at least prolong -...
Source: Asbestos and Mesothelioma News - October 11, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Legislation, Laws & Litigation Source Type: news

Is Mesothelioma Breakthrough Evolving at University of Vermont Laboratory?
Researchers at University of Vermont may have uncovered a better way to target mesothelioma tumors, and reduce the side effects of current treatments. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 7, 2013 Category: Environmental Health Authors: TimPovtak Tags: Mesothelioma Source Type: news

Government Shutdown Doesn’t Stop Mesothelioma Cancer Care at NIH
Although the government shutdown affected some clinical trials at the National Institutes of Health, mesothelioma cancer care continues. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - October 3, 2013 Category: Environmental Health Authors: TimPovtak Tags: Mesothelioma Source Type: news

Government Shutdown Doesn't Stop Mesothelioma Cancer Care at NIH
Mesothelioma cancer patients being treated at the National Institutes of Health (NIH) already enrolled in a clinical trial are not being affected  by the partial federal government shutdown that began earlier this week. Although 75 percent of the staff – an estimated 14,000 employees – has been put on temporary leave because of the shutdown, more than 1,400 ongoing clinical trials, covering a myriad of diseases, are continuing, according to National Institutes of Health spokesman John Burklow. "Our patient care will continue," assured another NIH employee. Although the shutdown won't affect those...
Source: Asbestos and Mesothelioma News - October 3, 2013 Category: Environmental Health Authors: Tim Povtak Tags: Mesothelioma Source Type: news

Despite Intense Political Debate, Mesothelioma Advocates Strongly Support Obamacare
While considerable debate is battled in Congress over the worth of the Affordable Care Act, known as Obamacare, cancer advocates strongly support it. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - September 30, 2013 Category: Environmental Health Authors: TimPovtak Tags: Legislation, Laws & Litigation Mesothelioma Mesothelioma Cancer Mesothelioma Research Treatment Source Type: news

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma
Tremelimumab, one of a new class of immunomodulatory monoclonal antibodies, has shown encouraging clinical activity and acceptable tolerability in patients with chemotherapy-resistant malignant mesothelioma, results of a single-arm phase II study show. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - September 27, 2013 Category: Cancer & Oncology Source Type: news

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma
Tremelimumab, one of a new class of immunomodulatory monoclonal antibodies, has shown encouraging clinical activity and acceptable tolerability in patients with chemotherapy-resistant malignant mesothelioma, results of a single-arm phase II study show. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - September 27, 2013 Category: Cancer & Oncology Source Type: news

Slide Show: Small-Cell Lung Cancer, Mesothelioma, and Thymoma
This lung cancer slide show features pathology images of small-cell lung carcinoma, neuroendocrine carcinomas, mesothelioma, and thymoma. (Source: Cancer Network)
Source: Cancer Network - September 26, 2013 Category: Cancer & Oncology Source Type: news

Leicester leads two groundbreaking trials into treatments for asbestos-related cancer
University of Leicester researchers are leading two major trials into treatments for a type of cancer which affects those exposed to asbestos. Professor Dean Fennell, of the University's Department of Cancer Studies and Molecular Medicine, is leading two groundbreaking trials into mesothelioma - a form of lung cancer strongly linked with exposure to asbestos. Mesothelioma most commonly starts in the inner lining of the chest wall, causing it to thicken, reducing lung capacity - which in turn puts a strain on other organs including the heart... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 24, 2013 Category: Consumer Health News Tags: Asbestos / Mesothelioma Source Type: news

Mesothelioma Survivor: Vermiculite Remains a Threat in American Homes
Mesothelioma survivor Bill Cawlfield is educating others about the dangers of the remaining vermiculite insulation in millions of American homes. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - September 19, 2013 Category: Environmental Health Authors: TimPovtak Tags: Asbestos Exposure & Bans Abatement EPA Featured Mesothelioma Mesothelioma Cancer Survivors Source Type: news